Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

See if 5-HTP helps with ADHD traits and eye movements

Official title: The Effect of 5-hydroxytryptophan on Microsaccades and Distractibility in Individual With High Levels of ADHD Traits: a Randomised, Double-blind Trial

Run by University of Sheffield · NCT07777328 · Data updated 2026-11-12

This study tests whether taking 5-HTP can reduce distractibility in adults with ADHD by comparing 5-HTP to a placebo during brain and eye-movement tasks.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity of Sheffield
Academic / other
Locations1 site (Sheffield, South Yorkshire)
StatusRecruiting
StartedNovember 25, 2025
Main results expectedFebruary 2027
Study endsJune 2027
Registry record updatedAugust 20, 2026
Trial IDNCT07777328 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–65 with ADHD traits who have normal or corrected vision and are not taking stimulants or serotonergic medications.

Probably not a fit

Participants with certain medications, lifestyle factors, or conditions may not experience benefit and may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–65 with ADHD-related traits will complete screening questionnaires and, if eligible, a in-person session at the University of Sheffield. Participants will receive either 200 mg or 300 mg of 5-HTP or a placebo, then perform cognitive tasks while eye movements are recorded, followed by a 90-minute waiting period and a second task run. The aim is to explore whether 5-HTP can influence attention and eye-movement patterns that are linked to distractibility. This is an early, pilot-type investigation using a short-term administration of a nutritional supplement. The study is exploratory and focused on initial signals of efficacy and safety in this context.

Why it matters

Potential benefit: If successful, 5-HTP could be studied further as a potential supplement to help manage distractibility in ADHD traits.

How similar studies have gone: Prior animal work suggested increased attention with 5-HTP, but human data in ADHD are limited and this study is among the initial human tests.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-65 years of age
* Normal or corrected to normal vision with contact lenses.
* Score of \<9 or \>14 on the ASRS v5 (assessed in pre screen questionnaire)

Exclusion Criteria:

* Current use of psychostimulant medication or medication for the treatment of ADHD
* Current use of medications known to impact the serotonergic system (e.g., SSRIs).
* Smoking or vaping
* Pregnancy
* Breast feeding
* Lactose intolerance
* Veganism
* Dyslexia

Where it's running

  • University of Sheffield
    Sheffield, South Yorkshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.